Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Clinical trial NCT00614523 · COMPLETED

Trial details

NCT number: NCT00614523
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

MDS Myelodysplastic Syndromes Thrombocytopenia

Start date: 2008-07-21
Primary completion: 2011-03-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.